Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Dopamine-transporter density in patients with ADHD.

Baughman FA Jr.

Lancet. 2000 Apr 22;355(9213):1460-1; author reply 1461-2. No abstract available.

PMID:
10791547
[PubMed - indexed for MEDLINE]
2.

Dopamine-transporter density in patients with ADHD.

Swanson JM.

Lancet. 2000 Apr 22;355(9213):1461; author reply 1461-2. No abstract available.

PMID:
10791548
[PubMed - indexed for MEDLINE]
3.

The early development of child psychopharmacogenetics.

Cook EH Jr.

J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1478-81. No abstract available.

PMID:
10596246
[PubMed - indexed for MEDLINE]
4.

Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE.

Neuropediatrics. 2003 Apr;34(2):77-80.

PMID:
12776228
[PubMed - indexed for MEDLINE]
5.

Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.

Krause KH, Dresel S, Krause J, Kung HF, Tatsch K, Lochmüller H.

J Neurol. 2002 Aug;249(8):1116-8. No abstract available.

PMID:
12420715
[PubMed - indexed for MEDLINE]
6.

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ.

Lancet. 1999 Dec 18-25;354(9196):2132-3.

PMID:
10609822
[PubMed - indexed for MEDLINE]
7.

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.

Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K.

Eur J Nucl Med. 2000 Oct;27(10):1518-24.

PMID:
11083541
[PubMed - indexed for MEDLINE]
8.

Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.

van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, Seibyl JP, Innis RB.

Am J Psychiatry. 2002 Feb;159(2):309-12.

PMID:
11823278
[PubMed - indexed for MEDLINE]
10.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
[PubMed - indexed for MEDLINE]
11.

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.

Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M.

Neurosci Biobehav Rev. 2003 Nov;27(7):605-13. Review.

PMID:
14624805
[PubMed - indexed for MEDLINE]
12.

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.

Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K.

Neurosci Lett. 2000 May 12;285(2):107-10.

PMID:
10793238
[PubMed - indexed for MEDLINE]
13.

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.

Biol Psychiatry. 2005 Feb 1;57(3):229-38.

PMID:
15691523
[PubMed - indexed for MEDLINE]
14.

Serotonin and the therapeutic effects of ritalin.

Volkow ND, Gatley SJ, Fowler JS, Wang GJ, Swanson J.

Science. 2000 Apr 7;288(5463):11. No abstract available.

PMID:
10766624
[PubMed - indexed for MEDLINE]
Free Article
15.

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response.

Winsberg BG, Comings DE.

J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1474-7.

PMID:
10596245
[PubMed - indexed for MEDLINE]
16.

Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.

Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD.

Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):306-11. Epub 2002 Nov 29.

PMID:
12552351
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

Swanson JM, Volkow ND.

Behav Brain Res. 2002 Mar 10;130(1-2):73-8. Review.

PMID:
11864720
[PubMed - indexed for MEDLINE]
18.

Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.

Rohde LA, Roman T, Szobot C, Cunha RD, Hutz MH, Biederman J.

Synapse. 2003 May;48(2):87-9.

PMID:
12619042
[PubMed - indexed for MEDLINE]
19.

Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.

Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M.

Int J Neuropsychopharmacol. 2002 Jun;5(2):111-3.

PMID:
12135534
[PubMed - indexed for MEDLINE]
20.

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.

Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH.

Pharmacogenetics. 2002 Aug;12(6):497-9.

PMID:
12172219
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk